Skip to Content
Merck
CN
  • Seizure progression triggered by IQSEC3 loss is mitigated by reducing activated microglia in mice.

Seizure progression triggered by IQSEC3 loss is mitigated by reducing activated microglia in mice.

Glia (2020-07-10)
Dongseok Park, Seungjoon Kim, Hyeonho Kim, Jungsu Shin, Hyeji Jung, Ji Won Um
ABSTRACT

IQSEC3, a guanine nucleotide exchange factor for ADP-ribosylation factors (ARF-GEFs) is specifically expressed at GABAergic synapses, and its loss increases seizure susceptibility in mice. However, the contribution of microglia to initiation and/or progression of seizures in IQSEC3-deficient mice has not been investigated. In the current study, we show that mice with hippocampal dentate gyrus (DG)-specific IQSEC3 knockdown (KD) exhibit microglial activation and death of DG granule cell. Furthermore, treatment of IQSEC3-KD mice with minocycline, an inhibitor of microglial activation, blocks DG granule neuron cell death and the occurrence of spontaneous seizures without affecting GABAergic synapse deficits or loss of somatostatin. Our results suggest that microglial activation is involved in a subset of IQSEC3-KD-induced epileptogenesis stages, and that its regulation could be an alternative strategy for managing epilepsy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-GAD67 Antibody, clone 1G10.2, clone 1G10.2, Chemicon®, from mouse
Sigma-Aldrich
Anti-Somatostatin Antibody, clone YC7, culture supernatant, clone YC7, Chemicon®